{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:48:07Z","timestamp":1792723687189,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["HT94252310488"],"award-info":[{"award-number":["HT94252310488"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013134","name":"US Department of Defense Military Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.kint.2026.04.021","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:12:31Z","timestamp":1779466351000},"page":"604-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and mechanistic effects of green mamba related peptide MQ232 in an orthologous mouse model of autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"110","author":[{"given":"Xiaofang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavini","family":"Nanayakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-342X","authenticated-orcid":false,"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka\u00efs","family":"Ramounet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvi-La\u00ebtitia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Mouillac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-9764","authenticated-orcid":false,"given":"Nicolas","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.04.021_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V95903","article-title":"Chloride and fluid secretion in polycystic kidney disease","volume":"9","author":"Sullivan","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib3","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib4","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.04.021_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","article-title":"Regulation of cAMP production in initial and terminal inner medullary collecting ducts","volume":"54","author":"Yasuda","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib7","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study","volume":"1","author":"Verani","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2026.04.021_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.04.021_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"10.1016\/j.kint.2026.04.021_bib11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2026.04.021_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2026.04.021_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.kint.2021.01.028","article-title":"The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1(RC\/RC) mouse model of autosomal dominant polycystic kidney disease","volume":"99","author":"Arroyo","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.114.213256","article-title":"Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury","volume":"349","author":"Aihara","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.kint.2026.04.021_bib16","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.04.021_bib17","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"2S","key":"10.1016\/j.kint.2026.04.021_bib18","first-page":"S1","article-title":"KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)","volume":"107","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib19","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience","volume":"6","author":"Higashihara","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2022.08.012","article-title":"Clinical pattern of tolvaptan-associated liver injury in trial participants with autosomal dominant polycystic kidney disease (ADPKD): an analysis of pivotal clinical trials","volume":"81","author":"Alpers","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.04.021_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pharmtox-040623-115054","article-title":"G protein-coupled receptor signaling: new insights define cellular nanodomains","volume":"64","author":"Lohse","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.kint.2026.04.021_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.kint.2026.04.021_bib23","doi-asserted-by":"crossref","first-page":"109649","DOI":"10.1016\/j.cellsig.2020.109649","article-title":"Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling","volume":"72","author":"Sussman","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2026.04.021_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cell.2016.07.004","article-title":"GPCR-G protein-beta-arrestin super-complex mediates sustained G protein signaling","volume":"166","author":"Thomsen","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.kint.2026.04.021_bib25","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1111\/bph.15814","article-title":"A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor","volume":"179","author":"Droctov\u00e9","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2026.04.021_bib26","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1073\/pnas.1620454114","article-title":"Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease","volume":"114","author":"Ciolek","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1681\/ASN.0000000505","article-title":"A snake toxin derivative for treatment of hyponatremia and polycystic kidney diseases","volume":"36","author":"Stanajic-Petrovic","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"100","key":"10.1016\/j.kint.2026.04.021_bib28","doi-asserted-by":"crossref","DOI":"10.3791\/52757","article-title":"Use of ultra-high field MRI in small rodent models of polycystic kidney disease for in vivo phenotyping and drug monitoring","author":"Irazabal","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.kint.2026.04.021_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10278-017-9978-1","article-title":"Performance of an artificial multi-observer deep neural network for fully automated segmentation of polycystic kidneys","volume":"30","author":"Kline","year":"2017","journal-title":"J Digit Imaging"},{"key":"10.1016\/j.kint.2026.04.021_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.kint.2020.07.040","article-title":"Automated total kidney volume measurements in pre-clinical magnetic resonance imaging for resourcing imaging data, annotations, and source code","volume":"99","author":"Edwards","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jneumeth.2008.05.003","article-title":"The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting","volume":"172","author":"Aldridge","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.kint.2026.04.021_bib32","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.RA120.015400","article-title":"Allosteric activation of proto-oncogene kinase Src by GPCR-beta-arrestin complexes","volume":"295","author":"Pakharukova","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.04.021_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303794120","article-title":"Signal transduction at GPCRs: allosteric activation of the ERK MAPK by \u03b2-arrestin","volume":"120","author":"Kahsai","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib34","doi-asserted-by":"crossref","first-page":"101369","DOI":"10.1016\/j.jbc.2021.101369","article-title":"The GPCR-\u03b2-arrestin complex allosterically activates C-Raf by binding its amino terminus","volume":"297","author":"Zang","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.04.021_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.kint.2026.04.021_bib36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1096\/fj.201700763R","article-title":"G protein-dependent signaling triggers a beta-arrestin-scaffolded p70S6K\/ rpS6 module that controls 5'TOP mRNA translation","volume":"32","author":"Trefier","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2026.04.021_bib37","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200573R","article-title":"Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by beta-arrestin\/ERK\/STAT3 pathway","volume":"36","author":"Zhang","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2026.04.021_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellsig.2006.05.020","article-title":"The V2 vasopressin receptor stimulates ERK1\/2 activity independently of heterotrimeric G protein signalling","volume":"19","author":"Charest","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2026.04.021_bib39","doi-asserted-by":"crossref","first-page":"E1028","DOI":"10.1073\/pnas.1112422109","article-title":"Engagement of \u03b2-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1\/2 activation","volume":"109","author":"Oligny-Longpr\u00e9","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bbrc.2007.05.062","article-title":"The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis","volume":"358","author":"McElroy","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2026.04.021_bib41","series-title":"Interrogating regulated intramembrane proteolysis of IGF-IR, and its role in cell migration","author":"O'Donoghue","year":"2023"},{"key":"10.1016\/j.kint.2026.04.021_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135700","article-title":"Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis","volume":"5","author":"Kashyap","year":"2020","journal-title":"JCI insight"},{"key":"10.1016\/j.kint.2026.04.021_bib43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2026.04.021_bib44","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","article-title":"Vasopressin antagonists in polycystic kidney disease","volume":"68","author":"Torres","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","article-title":"Analysis of baseline parameters in the HALT polycystic kidney disease trials","volume":"81","author":"Torres","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000456087","article-title":"Rationale and design of a clinical trial investigating tolvaptan safety and efficacy in autosomal dominant polycystic kidney disease","volume":"45","author":"Torres","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib47","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41467-025-59114-5","article-title":"Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for tolvaptan and mambaquaretin toxin","volume":"16","author":"Fouillen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2026.04.021_bib48","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1152\/ajprenal.00330.2013","article-title":"Tolvaptan as a tool in renal physiology","volume":"306","author":"Miranda","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib49","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jcph.880","article-title":"Pharmacokinetics and pharmacodynamics of tolvaptan in autosomal dominant polycystic kidney disease: phase 2 trials for dose selection in the pivotal phase 3 trial","volume":"57","author":"Shoaf","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.kint.2026.04.021_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","article-title":"Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/gfab278","article-title":"Vaptans or voluntary increased hydration to protect the kidney: how do they compare?","volume":"38","author":"Bankir","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.04.021_bib52","doi-asserted-by":"crossref","first-page":"F931","DOI":"10.1152\/ajprenal.00604.2013","article-title":"The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors","volume":"306","author":"Juul","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrneph.2013.22","article-title":"Vasopressin: a novel target for the prevention and retardation of kidney disease?","volume":"9","author":"Bankir","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib54","doi-asserted-by":"crossref","first-page":"F20","DOI":"10.1152\/ajprenal.00350.2024","article-title":"Vasopressin V1a and V1b receptor antagonism does not affect the efficacy of tolvaptan in polycystic kidney disease","volume":"329","author":"Wang","year":"2025","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib55","article-title":"\u03b2-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor","author":"Daly","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.kint.2026.04.021_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87754.3","article-title":"\u03b2-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor","volume":"12","author":"Daly","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.kint.2026.04.021_bib57","doi-asserted-by":"crossref","first-page":"27849","DOI":"10.1074\/jbc.M112.445098","article-title":"Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin","volume":"288","author":"Feinstein","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.04.021_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adf6206","article-title":"Sustained Galpha(s) signaling mediated by vasopressin type 2 receptors is ligand dependent but endocytosis and beta-arrestin independent","volume":"18","author":"Teixeira","year":"2025","journal-title":"Sci Signal"},{"key":"10.1016\/j.kint.2026.04.021_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tem.2004.11.008","article-title":"\"Ins and outs\" of seven-transmembrane receptor signalling to ERK","volume":"16","author":"Werry","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.kint.2026.04.021_bib60","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2024.05.007","article-title":"GPCR-dependent and -independent arrestin signaling","volume":"45","author":"Gurevich","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.kint.2026.04.021_bib61","doi-asserted-by":"crossref","first-page":"F57","DOI":"10.1152\/ajprenal.00124.2023","article-title":"Vasopressin V2 receptor, tolvaptan, and ERK1\/2 phosphorylation in the renal collecting duct","volume":"326","author":"Khan","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026491118","article-title":"Scaffolding mechanism of arrestin-2 in the cRaf\/MEK1\/ERK signaling cascade","volume":"118","author":"Qu","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib63","article-title":"Targeting lysine-specific demethylase 1A inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis","volume":"36","author":"Zhang","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2026.04.021_bib64","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib65","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0409534102","article-title":"Different G protein-coupled receptor kinases govern G protein and \u03b2-arrestin-mediated signaling of V2 vasopressin receptor","volume":"102","author":"Ren","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib66","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.1038\/ncomms15054","article-title":"A new inhibitor of the beta-arrestin\/AP2 endocytic complex reveals interplay between GPCR internalization and signalling","volume":"8","author":"Beautrait","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2026.04.021_bib67","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.021_bib68","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","article-title":"Tolvaptan inhibits ERK-dependent cell proliferation, Cl(-) secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin","volume":"301","author":"Reif","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib69","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1074\/jbc.M111.268797","article-title":"V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists","volume":"287","author":"Takahashi","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2026.04.021_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14200","article-title":"Plasma concentrations of peptide hormones: unrealistic levels of vasopressin (AVP), oxytocin (OXT), and brain natriuretic peptide (BNP)","volume":"240","author":"Bie","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.kint.2026.04.021_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.kint.2026.04.021_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1523-1755.1999.00569.x","article-title":"Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells","volume":"56","author":"Andersen-Beckh","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib73","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1091\/mbc.e04-04-0337","article-title":"Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells","volume":"15","author":"Robben","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.kint.2026.04.021_bib74","doi-asserted-by":"crossref","first-page":"F87","DOI":"10.1152\/ajprenal.90509.2008","article-title":"Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells","volume":"296","author":"Raychowdhury","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib75","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ki.1984.219","article-title":"Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue","volume":"26","author":"Shimizu","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.021_bib76","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/endrev\/bnaf019","article-title":"G protein-coupled and membrane tyrosine kinase receptor relationships yield therapeutic opportunities","volume":"46","author":"Girnita","year":"2025","journal-title":"Endocr Rev"},{"key":"10.1016\/j.kint.2026.04.021_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/stke.3922007pe35","article-title":"GPCRs signaling directly through Src-family kinases","author":"McGarrigle","year":"2007","journal-title":"Sci STKE"},{"key":"10.1016\/j.kint.2026.04.021_bib78","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.3390\/ijms22126489","article-title":"New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation","volume":"22","author":"Berndt","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2026.04.021_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/en.2008-0068","article-title":"Sustained elevated levels of circulating vasopressin selectively stimulate the proliferation of kidney tubular cells via the activation of V2 receptors","volume":"150","author":"Alonso","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2026.04.021_bib80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.kint.2025.08.039","article-title":"Inactivation of Pkd2 in adult mice results in delayed cyst formation and identifies sex as a major modifier of disease severity","volume":"109","author":"Outeda","year":"2026","journal-title":"Kidney Int"},{"issue":"4 Pt 2","key":"10.1016\/j.kint.2026.04.021_bib81","first-page":"R923","article-title":"Increased plasma osmolality stimulates peripheral and central vasopressin release in male and female rats","volume":"267","author":"Ota","year":"1994","journal-title":"Am J Physiol"},{"issue":"91","key":"10.1016\/j.kint.2026.04.021_bib82","first-page":"1893","article-title":"Sex differences in osmotic regulation of AVP and renal sodium handling","volume":"2001","author":"Stachenfeld","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/JOE-16-0311","article-title":"Oestradiol effects on neuroendocrine responses induced by water deprivation in rats","volume":"231","author":"Vilhena-Franco","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.kint.2026.04.021_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.kint.2026.04.021_bib85","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/HJH.0000000000000610","article-title":"Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults","volume":"33","author":"Schoen","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.kint.2026.04.021_bib86","doi-asserted-by":"crossref","first-page":"R700","DOI":"10.1152\/ajpregu.00500.2006","article-title":"Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease","volume":"292","author":"Perucca","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib87","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000441-198804000-00017","article-title":"Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension","volume":"295","author":"Share","year":"1988","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.kint.2026.04.021_bib88","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00199.2010","article-title":"Sex differences in vasopressin V(2) receptor expression and vasopressin-induced antidiuresis","volume":"300","author":"Liu","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib89","doi-asserted-by":"crossref","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","article-title":"Gender difference in antidiuretic response to desmopressin","volume":"300","author":"Juul","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib90","doi-asserted-by":"crossref","first-page":"1409271","DOI":"10.3389\/fphar.2024.1409271","article-title":"Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics","volume":"15","author":"Hendriksen","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.kint.2026.04.021_bib91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.kint.2026.04.021_bib92","doi-asserted-by":"crossref","first-page":"112390","DOI":"10.1016\/j.mce.2024.112390","article-title":"Vasopressinergic sexual dimorphism: sex chromosome complement and organizational hormonal effects","volume":"594","author":"Dadam","year":"2024","journal-title":"Mol Cell Endocrinol"},{"issue":"Pt 3","key":"10.1016\/j.kint.2026.04.021_bib93","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1113\/jphysiol.2003.046920","article-title":"Oestrogen effects on urine concentrating response in young women","volume":"552","author":"Stachenfeld","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1507\/endocrj1954.35.267","article-title":"Effect of ovarian steroids on cyclic adenosine 3':5'-monophosphate production stimulated by arginine vasopressin in rat renal monolayer cultured cells","volume":"35","author":"Hatano","year":"1988","journal-title":"Endocrinol Jpn"},{"issue":"Pt 2","key":"10.1016\/j.kint.2026.04.021_bib95","first-page":"R951","article-title":"Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats","volume":"268","author":"Wang","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib96","doi-asserted-by":"crossref","first-page":"F305","DOI":"10.1152\/ajprenal.00685.2014","article-title":"Estradiol regulates AQP2 expression in the collecting duct: a novel inhibitory role for estrogen receptor alpha","volume":"309","author":"Cheema","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2026.04.021_bib97","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1535370213489437","article-title":"Follicle growth, ovulation, and luteal formation in primates and rodents: a comparative perspective","volume":"238","author":"Chaffin","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.kint.2026.04.021_bib98","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.112.083550","article-title":"Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model","volume":"83","author":"Valentino","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.kint.2026.04.021_bib99","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/brain\/awad052","article-title":"Sex-dependent effects of acute stress on amyloid-beta in male and female mice","volume":"146","author":"Edwards","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.kint.2026.04.021_bib100","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4103\/1673-5374.389637","article-title":"Sexual dimorphism of G protein-coupled receptor signaling in the brain","volume":"19","author":"Aljoudi","year":"2024","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.kint.2026.04.021_bib101","doi-asserted-by":"crossref","first-page":"879962","DOI":"10.3389\/fendo.2022.879962","article-title":"Sexual dimorphic effects of igf1 deficiency on metabolism in zebrafish","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2026.04.021_bib102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1210\/endo.137.3.8603593","article-title":"Temporal changes in insulin-like growth factor I, c-fos, and c-jun gene expression during hyperplastic kidney growth in weanling rats","volume":"137","author":"Mulroney","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2026.04.021_bib103","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1210\/endo.141.3.7353","article-title":"Early hyperplastic renal growth after uninephrectomy in adult female rats","volume":"141","author":"Mulroney","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2026.04.021_bib104","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.ekir.2021.06.033","article-title":"Urinary aquaporin 2 as a potential indicator predicting tolvaptan response in patients with ADPKD","volume":"6","author":"Makabe","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.04.021_bib105","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1073\/pnas.0509663103","article-title":"An L-RNA-based aquaretic agent that inhibits vasopressin in vivo","volume":"103","author":"Purschke","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.04.021_bib106","doi-asserted-by":"crossref","first-page":"107926","DOI":"10.1016\/j.jbc.2024.107926","article-title":"How to target membrane proteins for degradation: bringing GPCRs into the TPD fold","volume":"300","author":"Korona","year":"2024","journal-title":"J Biol Chem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826004023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826004023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:44:52Z","timestamp":1787219092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826004023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0085253826004023"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.04.021","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and mechanistic effects of green mamba related peptide MQ232 in an orthologous mouse model of autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.06.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}